"advanced breast cancer" trang 2 - tải miễn phí từ tailieunhanh
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
10    5    1
Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults

Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults
10    5    1
Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients

Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
13    53    0
An ongoing case-control study to evaluate the NHS breast screening programme

An ongoing case-control study to evaluate the NHS breast screening programme
11    54    1
Sách: Breast Cancer (American cancer society quick facts)

Sách: Breast Cancer (American cancer society quick facts)
330    102    0
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
7    43    0
Granulocyte-colony stimulating factorassociated aortitis in a woman with advanced breast cancer: A case report and review of the literature

Granulocyte-colony stimulating factorassociated aortitis in a woman with advanced breast cancer: A case report and review of the literature
5    76    0
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study
9    86    0
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
11    66    0
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: Characteristics and survival data
7    77    0
Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer

Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
10    74    1
Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial
6    60    1
Burden of early, advanced and metastatic breast cancer in The Netherlands

Burden of early, advanced and metastatic breast cancer in The Netherlands
11    43    1
Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?

Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?
9    45    1
Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: A retrospective cohort analysis

Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: A retrospective cohort analysis
11    30    1
Ixazomib in combination with carboplatin in pretreated women with advanced triplenegative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

Ixazomib in combination with carboplatin in pretreated women with advanced triplenegative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
9    60    1
SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial

SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial
8    54    1
Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial
7    73    1
Factors influencing diagnosis delay of advanced breast cancer in Moroccan women

Factors influencing diagnosis delay of advanced breast cancer in Moroccan women
8    55    1
Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: A metaanalysis of 19 case-control studies

Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: A metaanalysis of 19 case-control studies
8    44    1